Ophthalmology Innovation Summit
Ophthalmology Innovation Summit
November 09, 2018
3 min watch
Save

VIDEO: Presbyopia-correcting eye drop formulation progresses in clinical trials

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

CHICAGO — At the Ophthalmology Innovation Summit at AAO, Elad Kedar, CEO of Orasis Pharmaceuticals, discusses the progress of the company’s eye drop CSF-1 for the treatment of presbyopia.